A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, March 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 87 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,051 followers.

A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for… https://t.co/tqtEiGYSy6 #breastcancer

Reply Repost Favourite

A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for… https://t.co/jTGRlqLTBC #breastcancer

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.